 method of ABI determination in
which the lower of the ankle pressures was used to calculate
the ABI. Thus, the individuals in this study might not be
fully representative of the universe of PAD patients with a
greater burden of disease. At present, the beneÔ¨Åt of antiplatelet therapy for patients with asymptomatic PAD and no
other clinical cardiovascular disease is unknown.
Statin therapy. The Heart Protection Study established the protective effects of statin therapy in reducing
mortality and cardiovascular events